Atlas Trials

An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

Clinical trial NCT01846468 · COMPLETED

Trial details

NCT number
NCT01846468
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Renal Insufficiency
Start date
2013-03-01
Primary completion
2014-06-28
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.